{"canonical":"https://abierto.us/opportunities/75n91024d00005","key":"75N91024D00005","url":"https://abierto.us/opportunities/75n91024d00005","title":"A--PREVENT IDIQ MATO RFP","solicitation_number":"75N91024D00005","notice_type":"a","open":false,"response_deadline":null,"first_posted":"2024-01-29","last_posted":"2024-01-31","department":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","subagency":"NATIONAL INSTITUTES OF HEALTH","office":"NIH NCI","naics":"541714","psc":"AN12","set_aside":null,"place_state":"OK","place_county":null,"place_county_name":null,"place_city":"4055000","place_city_name":"Oklahoma City","winner":"UNIVERSITY OF OKLAHOMA","award_amount":"149995000.00","publications":[{"notice_id":"6fe40644401a45eca74e10f015c711ad","title":"A--PREVENT IDIQ MATO RFP","solicitation_number":"75N91024D00005","notice_type":"a","base_type":"o","posted":"2024-01-29","posted_at":null,"due_at":null,"due_date":null,"cancelled":null,"archived":null,"archive_date":"2024-02-07","award_number":"75N91024D00005","awardee_name":"UNIVERSITY OF OKLAHOMA Oklahoma City","amount":"149995000.00","link_sam":"https://sam.gov/workspace/contract/opp/6fe40644401a45eca74e10f015c711ad/view","enriched":false,"history":[]},{"notice_id":"828a2cf3019d4988acb882feeeb9dd6f","title":"A--PREVENT IDIQ MATO RFP","solicitation_number":"75N91024D00005","notice_type":"a","base_type":"a","posted":"2024-01-31","posted_at":null,"due_at":null,"due_date":null,"cancelled":null,"archived":null,"archive_date":"2024-02-08","award_number":"75N91024D00005","awardee_name":"UNIVERSITY OF OKLAHOMA Oklahoma City","amount":"149995000.00","link_sam":"https://sam.gov/workspace/contract/opp/828a2cf3019d4988acb882feeeb9dd6f/view","enriched":false,"history":[]}],"latest_notice_id":"828a2cf3019d4988acb882feeeb9dd6f","first_type":"a","notices":[{"award":{"date":"2024-01-23","amount":"149995000.00","number":"75N91024D00005","awardee":{"raw":"UNIVERSITY OF OKLAHOMA Oklahoma City OK 73104 USA","name":"UNIVERSITY OF OKLAHOMA Oklahoma City","location":{"zip":"73104","state":{"code":"OK"},"country":{"code":"USA"}}}},"dates":{"posted":"2024-01-29","award_date":"2024-01-23"},"links":{"sam":"https://sam.gov/workspace/contract/opp/6fe40644401a45eca74e10f015c711ad/view"},"naics":{"codes":["541714"],"primary":"541714"},"title":"A--PREVENT IDIQ MATO RFP","agency":{"office":{"code":"75N910","name":"NIH NCI"},"subtier":{"code":"7529","name":"NATIONAL INSTITUTES OF HEALTH"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-02-07","archive_type":"auto15"},"contacts":[{"name":"TAYLOR, RICHARD","role":"primary","email":"rich.taylor@nih.gov","phone":"+1 717 339 9735"}],"base_type":{"code":"o","label":"Solicitation"},"notice_id":"6fe40644401a45eca74e10f015c711ad","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"739d328b7859d96823d1aad9a98ae95214abf5446d300391786dfa72b5bc9149","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"PREVENT EFFICACY Pool: This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structured approach to drug and vaccine development, from discovery to the clinic. This contract is a part of a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) pool to procure services related to Preclinical Efficacy and Intermediate Endpoint Biomarkers, which is also referred to as the Efficacy Pool.","origin":"extract"},"notice_type":{"code":"a","label":"Award Notice"},"schema_version":1,"solicitation_number":"75N91024D00005","place_of_performance":{"zip":"73126","city":{"name":"Oklahoma City"},"state":{"code":"OK"},"country":{"code":"USA"}},"product_service_code":"AN12"},{"award":{"date":"2024-01-24","amount":"149995000.00","number":"75N91024D00005","awardee":{"raw":"UNIVERSITY OF OKLAHOMA Oklahoma City OK 73104 USA","name":"UNIVERSITY OF OKLAHOMA Oklahoma City","location":{"zip":"73104","state":{"code":"OK"},"country":{"code":"USA"}}}},"dates":{"posted":"2024-01-31","award_date":"2024-01-24"},"links":{"sam":"https://sam.gov/workspace/contract/opp/828a2cf3019d4988acb882feeeb9dd6f/view"},"naics":{"codes":["541714"],"primary":"541714"},"title":"A--PREVENT IDIQ MATO RFP","agency":{"office":{"code":"75N910","name":"NIH NCI"},"subtier":{"code":"7529","name":"NATIONAL INSTITUTES OF HEALTH"},"department":{"code":"075","name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF"},"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"organization_type":"OFFICE"},"status":{"active":false,"archive_date":"2024-02-08","archive_type":"auto15"},"contacts":[{"name":"TAYLOR, RICHARD","role":"primary","email":"rich.taylor@nih.gov","phone":"+1 717 339 9735"}],"base_type":{"code":"a","label":"Award Notice"},"notice_id":"828a2cf3019d4988acb882feeeb9dd6f","provenance":{"extract":{"url":"https://s3.amazonaws.com/falextracts/Contract%20Opportunities/Archived%20Data/FY2024_archived_opportunities.csv","etag":"\"d582488fe153a9f11bf629913d176ffc-137\"","fetched_at":"2026-09-16T19:07:39.720164Z","row_sha256":"e7a38ba8753423d8f50db82133fb44f24395f4bcd7f110c5935afe2afe8ca8fc","last_modified":"2026-09-13T14:47:40Z"},"updated_at":"2026-09-16T19:07:39.720164Z","first_seen_at":"2026-09-16T19:07:39.720164Z"},"description":{"text":"PREVENT EFFICACY Pool: This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structured approach to drug and vaccine development, from discovery to the clinic. This contract is a part of a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) pool to procure services related to Preclinical Efficacy and Intermediate Endpoint Biomarkers, which is also referred to as the Efficacy Pool.","origin":"extract"},"notice_type":{"code":"a","label":"Award Notice"},"schema_version":1,"solicitation_number":"75N91024D00005","place_of_performance":{"zip":"73126","city":{"name":"Oklahoma City"},"state":{"code":"OK"},"country":{"code":"USA"}},"product_service_code":"AN12"}],"due_at":null,"due_date":null,"closes_at":null,"awardable":false,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N910","office_name":"NIH NCI","state":"OK","county":null,"county_name":null,"city":"4055000","city_name":"Oklahoma City","country":"USA","winner_key":"GY8NMUZQXVS7","amount":"149995000.00","linked_awards":2,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z","principal_notice_id":"828a2cf3019d4988acb882feeeb9dd6f","description":{"text":"PREVENT EFFICACY Pool: This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structured approach to drug and vaccine development, from discovery to the clinic. This contract is a part of a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) pool to procure services related to Preclinical Efficacy and Intermediate Endpoint Biomarkers, which is also referred to as the Efficacy Pool.","html":null,"origin":"extract"},"contacts":[{"name":"TAYLOR, RICHARD","role":"primary","email":"rich.taylor@nih.gov","phone":"+1 717 339 9735"}],"place_of_performance":{"zip":"73126","city":{"name":"Oklahoma City"},"state":{"code":"OK"},"country":{"code":"USA"}},"office_address":{"zip":"20892","city":"Bethesda","state":"MD","country":"USA"},"naics_codes":["541714"],"award":{"date":"2024-01-24","amount":"149995000.00","number":"75N91024D00005","awardee":{"raw":"UNIVERSITY OF OKLAHOMA Oklahoma City OK 73104 USA","name":"UNIVERSITY OF OKLAHOMA Oklahoma City","location":{"zip":"73104","state":{"code":"OK"},"country":{"code":"USA"}}}},"attachments":[],"awards":[{"award_key":"CONT_IDV_75N91024D00005_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N91024D00005_7529/","piid":"75N91024D00005","parent_piid":null,"award_type":null,"vendor_key":"GY8NMUZQXVS7","recipient_name":"UNIVERSITY OF OKLAHOMA","recipient_uei":"GY8NMUZQXVS7","recipient_cage":"4B862","recipient_city":"OKLAHOMA CITY","recipient_state":"OK","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2024-01-24","last_action_date":"2026-07-09","actions":6,"obligated":"0","current_total_value":null,"potential_total_value":"149995000.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":9,"description":"PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM","method":"piid","confidence":"high","evidence":["award number 75N91024D00005 equals the contract number","same awarding office 75N910"],"opportunity_key":null,"opportunity_title":null}],"related":[{"key":"75N98026R00109","latest_notice_id":"5ab4cf48d42c495aabef1d6cdf21acf8","title":"NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM","solicitation_number":"75N98026R00109","notice_type":"o","first_type":"o","first_posted":"2026-07-10","last_posted":"2026-08-10","notices":5,"due_at":"2026-09-21T21:00:00Z","due_date":"2026-09-21","closes_at":"2026-09-21T21:00:00Z","awardable":true,"open":true,"dept_key":"d-075","dept_name":"HEALTH AND HUMAN SERVICES, DEPARTMENT OF","sub_key":"s-7529","sub_name":"NATIONAL INSTITUTES OF HEALTH","office_key":"o-75N910","office_name":"NIH NCI","naics":"54171","psc":"AN12","set_aside":"SBA","state":null,"county":null,"county_name":null,"city":null,"city_name":null,"country":"USA","winner":null,"winner_key":null,"amount":null,"linked_awards":0,"cancelled":false,"archived":false,"updated_at":"2026-09-16T21:18:12.857524Z"}]}